About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.21.203517607132.2615
Domestic EquitiesCipla Ltd.9.35899186314.2397
Domestic EquitiesMAX Healthcare Institute Ltd8.759312135813.3275
Domestic EquitiesDivi's Laboratories Ltd.8.29722074012.6244
Domestic EquitiesDr. Reddy's Laboratories Ltd.7.75119961511.7934
Domestic EquitiesApollo Hospitals Enterprise Ltd.7.56841650511.5155
Domestic EquitiesLupin Ltd.5.4339394538.2678
Domestic EquitiesFortis Healthcare Ltd.3.8338850885.8332
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.7300170845.6753
Domestic EquitiesAurobindo Pharma Ltd.3.6882456575.6117
Domestic EquitiesMankind Pharma Ltd2.9888184464.5475
Domestic EquitiesAlkem Laboratories Ltd.2.921386884.4448
Domestic EquitiesLaurus Labs Ltd.2.5362639053.8589
Domestic EquitiesZydus Lifesciences Ltd.2.3803407733.6217
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.2311245783.3947
Domestic EquitiesIPCA Laboratories Ltd.2.0890226843.1785
Domestic EquitiesAbbott India Ltd.1.67718512.5517
Domestic EquitiesBiocon Ltd.1.5554735422.3666
Domestic EquitiesSyngene International Ltd.1.2866308751.9576
Domestic EquitiesGranules India Ltd.0.7088236611.0785
Total 99.9990 152.1505
Cash & Cash Equivalents and Net AssetsTREPS0.0089 0.0135
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.0079 -0.0120
Total 0.0010 0.0015
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.